Drägerwerk stock gets Berenberg Buy rating and EUR156 target
Published on 11/12/2026 at 10:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBerenberg sees margin upside
- Berenberg began coverage with a Buy rating and expects a profitability inflection driven by Drägerwerk's margin strategy.
- The bank forecasts 12.3% annual EBIT growth through 2028 and sees the Capital Markets Day as a potential source of further detail.
- Drägerwerk's Medical division is expected to recover from 2028 as product mix and manufacturing efficiency improve.
Berenberg has started coverage of Drägerwerk AG & Co. KGaA with a Buy rating, identifying a potential profitability inflection for the medical and safety technology group. Investing.com reported the initiation on Wednesday, November 11, citing a EUR156 price target and the bank's margin-focused investment case.
The research firm forecasts compound annual EBIT growth of 12.3% through 2028. It sees the group EBIT margin rising from 6.7% in 2025 to 8.4% in 2028, while sales are projected to grow by 5.2% a year from 2026 through 2028.
Safety leads the operating case
Berenberg attributes much of the expected improvement to Drägerwerk's Safety division. The bank said operations have improved after the supply-chain disruptions of 2022, supported by price management, better procurement and lean-management measures.
The Medical division is expected to recover from 2028. Berenberg points to a richer product mix, manufacturing efficiencies and the lifting of a Food and Drug Administration warning letter, which it says reopens the US patient-monitoring market.
The bank's earnings estimates are 14% above consensus for 2027 and 2028. Its analysts argue that the market is underestimating operational leverage in Safety and the recovery potential in Medical. Berenberg models a mid-cycle EBIT margin of 8.4% in 2028 and 8.7% in 2030, below management's 10% target for 2030.
Capital Markets Day is next
Drägerwerk stock traded at 102.10 euros on Lang & Schwarz at 08:57 CET on Wednesday, November 11. Berenberg expects the company's Capital Markets Day in Lübeck on November 18 to provide more detail on the margin-improvement plan.
Drägerwerk stock at a glance
- Company: Drägerwerk AG & Co. KGaA
- ISIN: DE0005550636
- Ticker: DRW3.DE
- Latest Lang & Schwarz quote: EUR 102.10 on November 11, 2026, at 08:57 CET
- Business: Medical and safety technology
Investors can follow the broader German market on the DAX market page.
More news and analyses on Drägerwerk stock.
